What is NDC 0781-3513?

0781-3513 is the product NDC for Enoxaparin Sodium Injection,USP, Enoxaparin sodium 150 mg/mL injection, solution, listed with the FDA by Sandoz Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Sandoz Inc., NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Enoxaparin Sodium Injection,USP?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Enoxaparin Sodium Injection,USP NDC 0781-3513

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-3513Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-3513Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0781-3513-63	0078135136300781351363	10 SYRINGE in 1 CARTON (0781-3513-63) / 1 mL in 1 SYRINGE (0781-3513-01)Marketed from Sep 28, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Enoxaparin Sodium Injection,USP
Generic name (nonproprietary): enoxaparin sodium injection,usp
Active ingredients: Enoxaparin sodium — 150 mg/mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Sandoz Inc.NDC labeler code 0781
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205660
Marketing start: Mar 15, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Low-Molecular-Weight (Chemical structure)
Identifiers: Product ID 0781-3513_5db52ac9-d161-24ca-e063-6394a90afc77SPL ID 5db52ac9-d161-24ca-e063-6394a90afc77SPL set ID 1e0ac5e2-329c-d0a8-e063-6394a90afba8RxCUI 854228, 854235, 854238, 854241, 854245, 854248, 854252UNII 8NZ41MIK1OUPC 0307813505631, 0307813460633, 0307813488019, 0307813510017, 0307813482017, 0307813510635, 0307813482635, 0307813460015, 0307813513018, 0307813502630, 0307813505013, 0307813488637, 0307813502012, 0307813513636
Pharmacologic class: Low Molecular Weight Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400781351363 followed by a unit qualifier and the quantity

Package 00781-3513-63. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Enoxaparin sodium injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness (1.1) Inpatient treatment of acute DVT with or without pulmonary embolism (1.2) Outpatient treatment of acute DVT without pulmonary embolism (1.2) Prophylaxis of ischemic complications of unstable angina and non−Q-wave myocardial infarction (MI) (1.3) Treatment of acute ST-segment elevation myocardial infarction (STEMI) managed medically or with subsequent percutaneous coronary intervention (PCI) (1.4) Enoxaparin sodium in…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0781-3513

What is NDC 0781-3513?: 0781-3513 is the product NDC for Enoxaparin Sodium Injection,USP, Enoxaparin sodium 150 mg/mL injection, solution, listed with the FDA by Sandoz Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Enoxaparin Sodium Injection,USP.
What is the active ingredient?: Enoxaparin sodium.
Who is the labeler?: Sandoz Inc., NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Enoxaparin Sodium Injection,USP?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 205660

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205660
Product	Strength	Form · route	Labeler	Product NDC
Enoxaparin Sodium Injection,USP	Enoxaparin sodium 40 mg/.4mL	Injection, SolutionSubcutaneous	Sandoz Inc.	0781-3482
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	Injection, SolutionSubcutaneous	NorthStar RxLLC	72603-175
Enoxaparin Sodium Injection,USP	Enoxaparin sodium 60 mg/.6mL	Injection, SolutionSubcutaneous	Sandoz Inc.	0781-3488
Enoxaparin Sodium	Enoxaparin sodium 60 mg/.6mL	Injection, SolutionSubcutaneous	NorthStar RxLLC	72603-185
Enoxaparin Sodium	Enoxaparin sodium 80 mg/.8mL	Injection, SolutionSubcutaneous	NorthStar RxLLC	72603-195
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	Injection, SolutionSubcutaneous	NorthStar RxLLC	72603-205
Enoxaparin Sodium	Enoxaparin sodium 120 mg/.8mL	Injection, SolutionSubcutaneous	NorthStar RxLLC	72603-215
Enoxaparin Sodium	Enoxaparin sodium 150 mg/mL	Injection, SolutionSubcutaneous	NorthStar RxLLC	72603-225
Enoxaparin Sodium Injection,USP	Enoxaparin sodium 80 mg/.8mL	Injection, SolutionSubcutaneous	Sandoz Inc.	0781-3502
Enoxaparin Sodium Injection,USP	Enoxaparin sodium 100 mg/mL	Injection, SolutionSubcutaneous	Sandoz Inc.	0781-3505
Enoxaparin Sodium Injection,USP	Enoxaparin sodium 120 mg/.8mL	Injection, SolutionSubcutaneous	Sandoz Inc.	0781-3510
Enoxaparin Sodium	Enoxaparin sodium 30 mg/.3mL	Injection, SolutionSubcutaneous	NorthStar RxLLC	72603-165
Enoxaparin Sodium Injection,USP	Enoxaparin sodium 30 mg/.3mL	Injection, SolutionSubcutaneous	Sandoz Inc.	0781-3460
Enoxaparin Sodium	Enoxaparin sodium 30 mg/.3mL	Injection, SolutionSubcutaneous	Hepalink USA Inc.	81952-123
Enoxaparin Sodium	Enoxaparin sodium 80 mg/.8mL	Injection, SolutionSubcutaneous	Hepalink USA Inc.	81952-128
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	Injection, SolutionSubcutaneous	Hepalink USA Inc.	81952-124
Enoxaparin Sodium	Enoxaparin sodium 60 mg/.6mL	Injection, SolutionSubcutaneous	Hepalink USA Inc.	81952-126
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	Injection, SolutionSubcutaneous	Hepalink USA Inc.	81952-130
Enoxaparin Sodium	Enoxaparin sodium 120 mg/.8mL	Injection, SolutionSubcutaneous	Hepalink USA Inc.	81952-132
Enoxaparin Sodium	Enoxaparin sodium 150 mg/mL	Injection, SolutionSubcutaneous	Hepalink USA Inc.	81952-135